← Open Payments lookup

GENA BYRD-TURNER: Open Payments

NPI 1932775632 · ROCKVILLE, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$822 in 32 payments from 10 companies in 2025. Trend: 2023 $255 · 2024 $18 · 2025 $822

Food & beverage: $822
CompanyPaymentsAmount
AstraZeneca Pharmaceuticals LP5$231
Takeda Pharmaceuticals U.S.A., Inc.3$98
Novartis Pharmaceuticals Corporation4$92
ARS Pharmaceuticals Operations, Inc.4$84
Regeneron Healthcare Solutions, Inc.4$84
CSL Behring4$66
GlaxoSmithKline, LLC.3$62
Amgen Inc.3$57
Grifols USA, LLC1$27
BioCryst US Sales Co., LLC1$22

Products named: TEZSPIRE, CUVITRU, NEFFY, DUPIXENT, Rhapsido, AIRSUPRA, TRELEGY ELLIPTA, Andembry.

Industry payments across MD — which companies pay providers there.